Works matching DE "ANAKINRA"
Results: 126
Evaluation of the effects of anakinra treatment on clinic and laboratory results in patients with COVID-19.
- Published in:
- Northern Clinics of Istanbul, 2023, v. 10, n. 2, p. 189, doi. 10.14744/nci.2022.01047
- By:
- Publication type:
- Article
Comparison of anakinra and tocilizumab in management of severe COVID-19: a retrospective cohort study.
- Published in:
- Turkish Journal of Medical Sciences, 2022, v. 52, n. 5, p. 1486, doi. 10.55730/1300-0144.5487
- By:
- Publication type:
- Article
The efficacy of anakinra compared to standard care of treatment for COVID-19: a meta-analysis.
- Published in:
- Turkish Journal of Medical Sciences, 2022, v. 52, n. 3, p. 547, doi. 10.55730/1300-0144.5345
- By:
- Publication type:
- Article
The protective effects of Anakinra in a neonatal rat model of necrotizing enterocolitis.
- Published in:
- Turkish Journal of Medical Sciences, 2021, v. 51, n. 5, p. 2727, doi. 10.3906/sag-2103-275
- By:
- Publication type:
- Article
The role of anakinra in the modulation of intestinal cell apoptosis and inflammatory response during ischemia/reperfusion.
- Published in:
- Turkish Journal of Medical Sciences, 2021, v. 51, n. 4, p. 2177, doi. 10.3906/sag-2008-258
- By:
- Publication type:
- Article
Anakinra, an interleukin-1 receptor antagonist, increases the morphine analgesic effect and decreases morphine tolerance development by modulating oxidative stress and endoplasmic reticulum stress in rats.
- Published in:
- Turkish Journal of Medical Sciences, 2020, v. 50, n. 8, p. 2048, doi. 10.3906/sag-2005-256
- By:
- Publication type:
- Article
Tocilizumab versus anakinra in COVID-19: results from propensity score matching.
- Published in:
- Frontiers in Immunology, 2023, p. 1, doi. 10.3389/fimmu.2023.1185716
- By:
- Publication type:
- Article
An Economic Comparison of Treatment Strategies with Anakinra in Systemic Juvenile Idiopathic Arthritis (sJIA).
- Published in:
- Open Access Rheumatology: Research & Reviews, 2021, v. 13, p. 257, doi. 10.2147/OARRR.S325400
- By:
- Publication type:
- Article
Anakinra or tocilizumab in patients admitted to hospital with severe covid-19 at high risk of deterioration (IMMCoVA): A randomized, controlled, open-label trial.
- Published in:
- PLoS ONE, 2023, v. 18, n. 12, p. 1, doi. 10.1371/journal.pone.0295838
- By:
- Publication type:
- Article
Anakinra for patients with COVID-19: an updated systematic review and meta-analysis.
- Published in:
- Signa Vitae, 2023, v. 19, n. 5, p. 47, doi. 10.22514/sv.2023.025
- By:
- Publication type:
- Article
The clinical role of anakinra in the armamentarium against familial Mediterranean fever.
- Published in:
- Expert Review of Clinical Immunology, 2024, v. 20, n. 5, p. 441, doi. 10.1080/1744666X.2023.2299230
- By:
- Publication type:
- Article
Antiepileptogenic Effects of Anakinra, Lamotrigine and Their Combination in a Lithium–Pilocarpine Model of Temporal Lobe Epilepsy in Rats.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 20, p. 15400, doi. 10.3390/ijms242015400
- By:
- Publication type:
- Article
The Anti-Atherosclerosis Effect of Anakinra, a Recombinant Human Interleukin-1 Receptor Antagonist, in Apolipoprotein E Knockout Mice.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 9, p. 4906, doi. 10.3390/ijms23094906
- By:
- Publication type:
- Article
The Preferential Use of Anakinra in Various Settings of FMF: A Review Applied to an Updated Treatment-Related Perspective of the Disease.
- Published in:
- 2022
- By:
- Publication type:
- Literature Review
Anakinra Activates Superoxide Dismutase 2 to Mitigate Inflammasome Activity.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 12, p. 6531, doi. 10.3390/ijms22126531
- By:
- Publication type:
- Article
Towards a Treatment for Neuroinflammation in Epilepsy: Interleukin-1 Receptor Antagonist, Anakinra, as a Potential Treatment in Intractable Epilepsy.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 12, p. 6282, doi. 10.3390/ijms22126282
- By:
- Publication type:
- Article
Anakinra in Refractory Multisystem Inflammatory Syndrome in Children (MIS-C).
- Published in:
- Indian Pediatrics, 2021, v. 58, n. 10, p. 994, doi. 10.1007/s13312-021-2340-1
- By:
- Publication type:
- Article
The effect of etanercept and anakinra on experimental type 2 diabetes pathology in rats.
- Published in:
- Acta Veterinaria Brno, 2021, v. 90, n. 4, p. 421, doi. 10.2754/avb202190040421
- By:
- Publication type:
- Article
A single-centre retrospective case series of Anakinra for incident calcium pyrophosphate deposition disease.
- Published in:
- 2023
- By:
- Publication type:
- Case Study
Safety and Efficacy Evaluation of PerkinRA in Comparison with Kineret in Systemic Juvenile Idiopathic Arthritis Patients.
- Published in:
- Biomedical & Biotechnology Research Journal, 2024, v. 8, n. 3, p. 363, doi. 10.4103/bbrj.bbrj_155_24
- By:
- Publication type:
- Article
Analysis of Anakinra Therapy for the Deficiency of Interleukin-1 Receptor Antagonist through Clinical Evidence.
- Published in:
- Journal of Clinical Medicine, 2024, v. 13, n. 4, p. 1026, doi. 10.3390/jcm13041026
- By:
- Publication type:
- Article
Treatment of cytokine storm syndrome with IL‐1 receptor antagonist anakinra in a patient with ARDS caused by COVID‐19 infection: A case report.
- Published in:
- Clinical Case Reports, 2020, v. 8, n. 12, p. 2990, doi. 10.1002/ccr3.3307
- By:
- Publication type:
- Article
Systemic inflammatory markers and EEG features of children with FIRES receiving anakinra.
- Published in:
- Annals of Clinical & Translational Neurology, 2023, v. 10, n. 3, p. 440, doi. 10.1002/acn3.51714
- By:
- Publication type:
- Article
Anakinra treatment for refractory cerebral autoinflammatory responses.
- Published in:
- Annals of Clinical & Translational Neurology, 2022, v. 9, n. 1, p. 91, doi. 10.1002/acn3.51500
- By:
- Publication type:
- Article
Anakinra usage in febrile infection related epilepsy syndrome: an international cohort.
- Published in:
- Annals of Clinical & Translational Neurology, 2020, v. 7, n. 12, p. 2467, doi. 10.1002/acn3.51229
- By:
- Publication type:
- Article
Cerebral autoinflammatory disease treated with anakinra.
- Published in:
- Annals of Clinical & Translational Neurology, 2018, v. 5, n. 11, p. 1428, doi. 10.1002/acn3.656
- By:
- Publication type:
- Article
Efficacy and safety of anakinra and canakinumab in PSTPIP1-associated inflammatory diseases: a comprehensive scoping review.
- Published in:
- Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2023.1339337
- By:
- Publication type:
- Article
Anakinra for Treatment-Resistant Kawasaki Disease: Evidence from a Literature Review.
- Published in:
- Pediatric Drugs, 2020, v. 22, n. 6, p. 645, doi. 10.1007/s40272-020-00421-3
- By:
- Publication type:
- Article
Intravenous anakinra for tisagenlecleucel-related toxicities in children and young adults.
- Published in:
- 2022
- By:
- Publication type:
- Letter
The Beneficial Outcome of Subsequent Treatment with Anakinra during the Chronic Phase of Febrile Infection-Related Epilepsy Syndrome (FIRES): A Case Report.
- Published in:
- Neurology International, 2023, v. 15, n. 4, p. 1489, doi. 10.3390/neurolint15040097
- By:
- Publication type:
- Article
Impact of anakinra use on clinical outcomes in children with moderate or severe multisystem inflammatory syndrome in children: a propensity score matched retrospective cohort study.
- Published in:
- Pediatric Rheumatology, 2023, v. 21, n. 1, p. 1, doi. 10.1186/s12969-023-00924-6
- By:
- Publication type:
- Article
Clinical outcomes and safety of anakinra in the treatment of multisystem inflammatory syndrome in children: a single center observational study.
- Published in:
- Pediatric Rheumatology, 2023, v. 21, n. 1, p. 1, doi. 10.1186/s12969-023-00858-z
- By:
- Publication type:
- Article
A rare cause of AA amyloidosis: Glomus tumor and treatment with anakinra—Case report and literature review.
- Published in:
- International Journal of Rheumatic Diseases, 2024, v. 27, n. 1, p. 1, doi. 10.1111/1756-185X.14984
- By:
- Publication type:
- Article
Successful use of subcutaneous anakinra in hemophagocytic lymphohistiocytosis precipitated by candidiasis in a patient with systemic lupus erythematosus: A case report and description of a novel therapeutic regimen.
- Published in:
- International Journal of Rheumatic Diseases, 2023, v. 26, n. 11, p. 2284, doi. 10.1111/1756-185X.14722
- By:
- Publication type:
- Article
An unusual presentation of immunoglobulin A gammopathy in a patient with Schnitzler's syndrome.
- Published in:
- International Journal of Rheumatic Diseases, 2023, v. 26, n. 10, p. 2085, doi. 10.1111/1756-185X.14718
- By:
- Publication type:
- Article
Efficacy of anakinra in a patient with systemic amyloidosis presenting as amyloidoma.
- Published in:
- International Journal of Rheumatic Diseases, 2018, v. 21, n. 2, p. 552, doi. 10.1111/1756-185X.13250
- By:
- Publication type:
- Article
A randomised placebo controlled trial of anakinra for treating pustular psoriasis: statistical analysis plan for stage two of the APRICOT trial.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Rasmussen's syndrome treated with anakinra.
- Published in:
- 2024
- By:
- Publication type:
- Case Study
Multifocal neutrophilic meningoencephalitis: a novel disorder responsive to anakinra.
- Published in:
- Journal of Neurology, 2021, v. 268, n. 8, p. 2995, doi. 10.1007/s00415-021-10431-x
- By:
- Publication type:
- Article
Anakinra as a first-line therapy for systemic juvenile idiopathic arthritis when nonsteroidal anti-inflammatory drug treatment fails: a single-center French retrospective study.
- Published in:
- ARP Rheumatology, 2024, v. 3, n. 4, p. 288, doi. 10.63032/TEVI1838
- By:
- Publication type:
- Article
Continuous IV infusion of anakinra.
- Published in:
- Frontiers in Pharmacology, 2023, p. 1, doi. 10.3389/fphar.2023.1162742
- By:
- Publication type:
- Article
Patients diagnosed with COVID-19 and treated with anakinra: a real-world study in the USA.
- Published in:
- Clinical & Experimental Immunology, 2022, v. 207, n. 2, p. 218, doi. 10.1093/cei/uxab024
- By:
- Publication type:
- Article
IL‐1 receptor antagonist, anakinra, prevents myocardial dysfunction in a mouse model of Kawasaki disease vasculitis and myocarditis.
- Published in:
- Clinical & Experimental Immunology, 2019, v. 198, n. 1, p. 101, doi. 10.1111/cei.13314
- By:
- Publication type:
- Article
Neutrophilic urticarial dermatosis without systemic disease: case report.
- Published in:
- 2024
- By:
- Publication type:
- Case Study
Glucocorticoids with low-dose anti-IL1 anakinra rescue in severe non-ICU COVID-19 infection: A cohort study.
- Published in:
- PLoS ONE, 2020, v. 15, n. 12, p. 1, doi. 10.1371/journal.pone.0243961
- By:
- Publication type:
- Article
Can emapalumab be life saving for refractory, recurrent, and progressive cytokine storm caused by COVID-19, which is resistant to anakinra, tocilizumab, and Janus kinase inhibitors.
- Published in:
- Indian Journal of Pharmacology, 2021, v. 53, n. 3, p. 226, doi. 10.4103/ijp.IJP_615_20
- By:
- Publication type:
- Article
Budget impact analysis of anakinra in the treatment of familial Mediterranean fever in Italy.
- Published in:
- Journal of Market Access & Health Policy, 2023, v. 11, n. 1, p. 1, doi. 10.1080/20016689.2023.2176091
- By:
- Publication type:
- Article
Anakinra Promotes M2 Microglia Activation during the Latent Phase of the Lithium-Pilocarpine Model of Temporal Lobe Epilepsy.
- Published in:
- Journal of Evolutionary Biochemistry & Physiology, 2024, v. 60, n. 2, p. 672, doi. 10.1134/S0022093024020182
- By:
- Publication type:
- Article
Erratum to: Effect of Anakinra on the Gene Expression of Receptors Activated by the Peroxisome Proliferator in the Rat Brain in the Lithium Pilocarpine Model of Epilepsy.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
Effect of Anakinra on the Gene Expression of Receptors Activated by the Peroxisome Proliferator in the Rat Brain in the Lithium Pilocarpine Model of Epilepsy.
- Published in:
- Journal of Evolutionary Biochemistry & Physiology, 2022, v. 58, n. 2, p. 598, doi. 10.1134/S0022093022020260
- By:
- Publication type:
- Article